Merit Medical Systems (MMSI) Given Coverage Optimism Rating of 0.16
News headlines about Merit Medical Systems (NASDAQ:MMSI) have trended somewhat positive this week, Accern reports. Accern ranks the sentiment of media coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Merit Medical Systems earned a media sentiment score of 0.16 on Accern’s scale. Accern also gave news stories about the medical instruments supplier an impact score of 45.7086298257779 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the immediate future.
These are some of the media headlines that may have effected Accern’s analysis:
- Cantel Medical Corp. (CMD) versus Merit Medical Systems (NASDAQ:MMSI) Financial Comparison (americanbankingnews.com)
- Kent W. Stanger Sells 7,400 Shares of Merit Medical Systems, Inc. (NASDAQ:MMSI) Stock (americanbankingnews.com)
- Merit Medical Systems, Inc. (NASDAQ:MMSI) Director A Scott Anderson Sells 25,000 Shares (americanbankingnews.com)
- Merit Medical Systems, Inc. (MMSI) Director Sells $127,377.06 in Stock (americanbankingnews.com)
MMSI has been the topic of a number of research reports. Craig Hallum initiated coverage on shares of Merit Medical Systems in a report on Monday, April 17th. They issued a “buy” rating and a $36.00 target price on the stock. Piper Jaffray Companies reiterated a “buy” rating and issued a $45.00 target price on shares of Merit Medical Systems in a report on Friday, July 28th. Bank of America Corporation initiated coverage on shares of Merit Medical Systems in a report on Thursday, July 20th. They issued a “buy” rating and a $44.00 target price on the stock. Sidoti reiterated a “buy” rating and issued a $46.00 target price (up from $41.00) on shares of Merit Medical Systems in a report on Wednesday, June 28th. Finally, Zacks Investment Research upgraded shares of Merit Medical Systems from a “hold” rating to a “buy” rating and set a $41.00 target price on the stock in a report on Thursday, June 22nd. One equities research analyst has rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the company. The stock presently has an average rating of “Buy” and an average target price of $39.74.
Merit Medical Systems (NASDAQ:MMSI) traded down 0.13% during midday trading on Friday, hitting $39.75. 295,424 shares of the stock were exchanged. The firm has a market capitalization of $1.99 billion, a price-to-earnings ratio of 56.62 and a beta of 1.26. Merit Medical Systems has a one year low of $20.70 and a one year high of $42.60. The company has a 50 day moving average price of $39.04 and a 200 day moving average price of $32.99.
Merit Medical Systems (NASDAQ:MMSI) last released its quarterly earnings data on Wednesday, July 26th. The medical instruments supplier reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.29 by $0.07. Merit Medical Systems had a net margin of 4.87% and a return on equity of 9.78%. The business had revenue of $186.50 million for the quarter, compared to analyst estimates of $181.46 million. During the same quarter last year, the firm earned $0.26 EPS. Merit Medical Systems’s quarterly revenue was up 23.4% compared to the same quarter last year. Equities analysts anticipate that Merit Medical Systems will post $1.26 EPS for the current year.
In related news, insider Richard W. Edelman sold 20,000 shares of Merit Medical Systems stock in a transaction that occurred on Friday, June 30th. The shares were sold at an average price of $37.62, for a total transaction of $752,400.00. Following the transaction, the insider now owns 35,000 shares of the company’s stock, valued at approximately $1,316,700. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Michael E. Stillabower sold 17,110 shares of Merit Medical Systems stock in a transaction that occurred on Friday, May 19th. The stock was sold at an average price of $33.71, for a total transaction of $576,778.10. Following the transaction, the director now directly owns 52,778 shares in the company, valued at approximately $1,779,146.38. The disclosure for this sale can be found here. Insiders have sold a total of 147,450 shares of company stock worth $5,607,192 in the last three months. 5.00% of the stock is owned by insiders.
TRADEMARK VIOLATION NOTICE: “Merit Medical Systems (MMSI) Given Coverage Optimism Rating of 0.16” was first posted by Watch List News and is owned by of Watch List News. If you are reading this article on another publication, it was illegally copied and reposted in violation of US & international copyright laws. The original version of this article can be viewed at https://www.watchlistnews.com/merit-medical-systems-mmsi-given-coverage-optimism-rating-of-0-16/1479905.html.
About Merit Medical Systems
Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.
Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.